CardiolRx

Toronto, Jan. 13, 2026 — Cardiol Therapeutics Inc. announced that it has surpassed the 50% patient enrollment milestone in...

Toronto, December 1, 2025 — New clinical data from the Phase II ARCHER trial reveal that CardiolRx™, Cardiol Therapeutics’...

NEW YORK, November 13, 2024 — Cardiol Therapeutics has secured a U.S. patent allowance protecting its next-generation cardiac therapies...